• SPX
  • $5,773.86
  • 1.07 %
  • $61.17
  • DJI
  • $42,123.95
  • 0.79 %
  • $329.35
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,172.39
  • -0.14 %
  • -$11.85
  • IXIC
  • $18,424.76
  • 1.35 %
  • $244.78
Nuvalent, Inc. (NUVL) Competitors

Nuvalent, Inc. (NUVL) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$91.52

$1.99

(2.22%)

Day's range
$88.48
Day's range
$91.52

Nuvalent, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ACLX
Arcellx, Inc. $86.74 $2.72 B -49.3 130 $110.32 M
ASND
Ascendis Pharma A/S $127.31 $7.77 B -14.19 879 $266.72 M
CERE
Cerevel Therapeutics Holdings, Inc. $44.96 $7.29 B -14.66 355 $0
CGEM
Cullinan Oncology, Inc. $15.76 $1.29 B -7.16 85 $0
DICE
DICE Therapeutics, Inc. $47.55 $2.27 B -21.91 71 $0
GPCR
Structure Therapeutics Inc. $39.88 $2.47 B -23.59 136 $0
KNSA
Kiniksa Pharmaceuticals, Ltd. $22.03 $1.35 B 146.62 297 $270.26 M
PCVX
Vaxcyte, Inc. $106.32 $7.72 B -16.54 254 $0
REPL
Replimune Group, Inc. $11.97 $485.18 M -2.44 331 $0
TVTX
Travere Therapeutics, Inc. $17.85 $542.80 M -1.32 380 $145.24 M
UTHR
United Therapeutics Corporation $381.21 $12.20 B 13.02 1168 $2.33 B
VRDN
Viridian Therapeutics, Inc. $23.02 $776.72 M -2.71 94 $314,000
VTYX
Ventyx Biosciences, Inc. $2.18 $229.83 M -1.01 73 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.